Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge

Vaccine

Volumn 23, Issue 29, 2005, Pages 3808-3813

  Karaca, K ^a   Bowen, R ^b   Austgen, L E ^b   Teehee, M ^b   Siger, L ^a   Grosenbaugh, D ^a   Loosemore, L ^c   Audonnet, J C ^a   Nordgren, R ^a   Minke, J M ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c Aventis Pasteur   (Canada)

Author keywords

Canarypox vectored West Nile vaccine; Cats; Dogs; Mosquito; West Nile virus

Indexed keywords

GENE PRODUCT; PROTEIN E; PROTEIN PRM; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE; VIRUS VECTOR; WEST NILE VACCINE;

AEDES ALBOPICTUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CANARYPOX VIRUS; CAT; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GENE EXPRESSION; HUMORAL IMMUNITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VACCINATION; VIREMIA; VIRUS INFECTION; VIRUS RECOMBINANT; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, VIRAL; CANARYPOX VIRUS; CAT DISEASES; CATS; DOG DISEASES; DOGS; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 21044459502     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.020     Document Type: Article

References (22)

1. Accessed on September 6, 2004 www.nwhc.usgs.gov/research/west_nile/ speciesAffected2004pdf
2. N. Komar West Nile viral Encephalitis Rev Sci Tech Off Int Epiz 19 2000 166 176
3. R.L. Reagan, M. Orlowski, and Bruceckner Response of young dogs to West Nile virus Proc Soc Exp Biol Med 82 1953 261 262
4. A. Bonaduce, M. Compagnucci, D. Bonaduce, C. Arpenti, and F. Martone Studies on the occurrence and distribution of HI antibodies against arboviruses in the serum of domestic mammals in Puglia Folia vet lat 7 1977 145 157
5. N.K. Blackburn, F. Reyers, W.L. Berry, and A.J. Shepherd Susceptibility of dogs to West Nile virus: a survey and pathogenicity trial J Comp Pathol 100 1989 59 66
6. N. Komar, N.A. Panella, and E. Boyce Exposure of domestic mammals to West Nile virus during outbreak of human Encephalitis, New York city, 1999 Emerg Infect Dis 4 2001 736 738
7. S. Buckweitz, S. Kleiboeker, K. Marioni, J. Ramos-Vara, A. Rottinghaus, and B. Schwabenton Serological, reverse transcriptase-polymerase chain reaction, and immunohistochemical detection of West Nile virus in a clinically affected dog J Vet Diagn Invest 15 2003 324 329
8. Kile JC, Panella NA, Chow CC, Komar N, MacNeil A, Bunning ML. Post-epidemic West Nile virus serosurvey of dogs and cats-Louisiana, 2002, Proc 139 Ann Meet AVMA, Denver CO, USA, 2003.
9. C.A. Lichtensteiger, K. Heinz-Taheny, T.S. Osborne, R.J. Novak, B.A. Lewis, and M.L. Firth West Nile virus Encephalitis and myocarditis in wolf and dog Emerg Infect Dis 9 2003 1303 1306
10. L.E. Austgen, R.A. Bowen, M.L. Bunning, B.S. Davis, C.J. Mitchell, and G.-J. Chang Experimental infection of cats and dogs with West Nile virus Emerg Infect Dis 10 2004 82 86
11. Accessed on September 6, 2004 http://www.ci.nyc.ny.us/html/doh/html/wnv/ wnvfaq13.html
12. J.M. Minke, L. Siger, K. Karaca, L. Austgen, P. Gordy, and R. Bowen Recombinant canarypox vaccine carrying PrM/E genes of West Nile virus protects horses against a West Nile virus mosquito-challenge Arch Virol 18 Suppl 2004 221 230
13. L. Siger, R. Bowen, K. Karaca, M. Murray, P. Gordy, and S. Loosemore Efficacy in horses of a single dose of an ALVAC recombinant West Nile Virus (WNV) vaccine, measured by protection to a natural challenge using WNV-infected mosquitoes Am J Vet Res 65 2004 1459 1462
14. M.L. Bunning, R.A. Bowen, B.C. Cropp, K.G. Sullivan, G.S. Davis, and N. Komar Experimental infection of horses with West Nile virus Emerg Inf Dis 8 2002 380 386
15. E. Paoletti, J. Tartaglia, and J. Taylor Safe and effective poxvirus vectors-NYVAC and ALVAC Dev Biol Stand 82 1994 65 69
16. B.S. Davis, G.J. Chang, B. Cropp, J.T. Roehrig, D.A. Martin, and C.J. Mitchell West nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a non-infectious recombinant antigen that can be used in enzyme-linked immunosorbant assays J Virol 75 2001 4040 4047
17. M.J. Engle, and M.S. Diamond Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice J Virol 77 2003 12941 12949
18. M.S. Diamond, B. Shrestha, A. Marri, D. Mahan, and M. Engle B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile Encephalitis virus J Virol 77 2003 2578 2586
19. Y. Wang, M. Lobigs, E. Lee, and A. Mullbacher CD8+ T cells mediate recovery and immunopathology in West Nile virus Encephalitis J Virol 77 2003 13323 13334
20. T. Wang, E. Scully, Z. Yin, J.H. Kim, S. Wang, and J. Yan IFN-γ-producing γδT cells help control murine West Nile virus infection J Immunol 171 2003 2524 2531
21. T. Wang, J.F. Anderson, L.A. Magnarelli, S.J. Wong, R.A. Koski, and E. Fikrig Immunization of mice against West Nile virus with recombinant envelope protein J Immunol 167 2001 5273 5277
22. E. Konishi, M. Yamaoka, Khin-Sane-Win, I. Kurane, K. Takada, and P.W. Mason The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese Encephalitis virus premembrane and envelope genes J Virol 73 1999 5527 5534